Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbAsia BioLabs was a Singapore-based life science tools and reagent company focused on manufacturing reagents for life science research and diagnostics. The company appears to have emphasized protein development and expression, enzyme supply, and PCR-related products such as genotyping kits and PCR enhancement reagents. Publicly available descriptions position it more as a research tools and diagnostics-enabling business than a therapeutic drug developer, with products intended to support laboratory research, testing, and assay development. Available company-registry data indicates the Singapore entity was incorporated in 2020 and has since been struck off, despite some commercial databases continuing to label it as active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AbAsia BioLabs.